Power your decentralized trial with an agile randomization and trial supply management solution that supports supply flexibility and optimization as well as adaptable direct to patient options.
Fact Sheet
Cenduit Interactive Response Technology
Run faster, higher quality patient-centric studies
Oct 17, 2022
Accelerate study start-up and amendments, simplify site and sponsor experience, reduce trial supply costs and improve study decision making while ensuring quality standards and patient safety during your trial with Cenduit Interactive Response Technology. Built on a robust, scalable platform, our patient-centric approach to technology delivery provides exceptional value and peace of mind for sponsors and their patients in clinical trials. Cenduit IRT is part of the Digital Patient Suite of IQVIA Technologies Orchestrated Clinical Trials (OCT), an end-to-end, patientcentric platform that provides an unparalleled data infrastructure, seamless connectivity and intuitive design to drive smarter, faster trials.
Related solutions
Interactive Response Technology
Patient Engagement Suite
Technology informed by unparalleled Decentralized Trials (DCT) operational experience and delivered at global scale.
Orchestrated Clinical Trials
Ease the burden on your sites and make it easier and more appealing for patients to enroll and remain engaged.
IQVIA Technologies
Combine data science, technology, and analytics driven by artificial intelligence to support new efficiencies and business insights -- without additional capital investment.
